244 related articles for article (PubMed ID: 31655136)
1. Candida auris: Clinical profile, diagnostic challenge and susceptibility pattern: Experience from a tertiary-care centre in South India.
Ninan MM; Sahni RD; Chacko B; Balaji V; Michael JS
J Glob Antimicrob Resist; 2020 Jun; 21():181-185. PubMed ID: 31655136
[TBL] [Abstract][Full Text] [Related]
2. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.
Kathuria S; Singh PK; Sharma C; Prakash A; Masih A; Kumar A; Meis JF; Chowdhary A
J Clin Microbiol; 2015 Jun; 53(6):1823-30. PubMed ID: 25809970
[TBL] [Abstract][Full Text] [Related]
3. Five-year profile of candidaemia at an Indian trauma centre: High rates of Candida auris blood stream infections.
Mathur P; Hasan F; Singh PK; Malhotra R; Walia K; Chowdhary A
Mycoses; 2018 Sep; 61(9):674-680. PubMed ID: 29738604
[TBL] [Abstract][Full Text] [Related]
4. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
5. Multidrug-resistant endemic clonal strain of Candida auris in India.
Chowdhary A; Anil Kumar V; Sharma C; Prakash A; Agarwal K; Babu R; Dinesh KR; Karim S; Singh SK; Hagen F; Meis JF
Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):919-26. PubMed ID: 24357342
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Vitek 2 system for antifungal susceptibility testing of
Siopi M; Pachoulis I; Leventaki S; Spruijtenburg B; Meis JF; Pournaras S; Vrioni G; Tsakris A; Meletiadis J
J Clin Microbiol; 2024 Apr; 62(4):e0152823. PubMed ID: 38501836
[TBL] [Abstract][Full Text] [Related]
7. Head-to-head comparison of CLSI, EUCAST, Etest and VITEK®2 results for Candida auris susceptibility testing.
Ceballos-Garzon A; Garcia-Effron G; Cordoba S; Rodriguez JY; Alvarez-Moreno C; Pape PL; Parra-Giraldo CM; Morales-López S
Int J Antimicrob Agents; 2022 Apr; 59(4):106558. PubMed ID: 35227828
[TBL] [Abstract][Full Text] [Related]
8. Candida auris Clinical Isolates from South Korea: Identification, Antifungal Susceptibility, and Genotyping.
Kwon YJ; Shin JH; Byun SA; Choi MJ; Won EJ; Lee D; Lee SY; Chun S; Lee JH; Choi HJ; Kee SJ; Kim SH; Shin MG
J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30728190
[No Abstract] [Full Text] [Related]
9. Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen.
Osei Sekyere J
Microbiologyopen; 2018 Aug; 7(4):e00578. PubMed ID: 29345117
[TBL] [Abstract][Full Text] [Related]
10. Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait.
Khan Z; Ahmad S; Al-Sweih N; Joseph L; Alfouzan W; Asadzadeh M
PLoS One; 2018; 13(4):e0195743. PubMed ID: 29630658
[TBL] [Abstract][Full Text] [Related]
11. Candida auris - Comparison of sensititre YeastOne and Vitek 2 AST systems for antifungal susceptibility testing - A single centre experience.
Patwardhan SA; Prayag PS; Soman RN; Purandare BD; Ramya S; Dawra R; Joshi R; Prayag AP
Indian J Med Microbiol; 2024 May; 50():100618. PubMed ID: 38795936
[TBL] [Abstract][Full Text] [Related]
12. Candida auris in Singapore: Genomic epidemiology, antifungal drug resistance, and identification using the updated 8.01 VITEK
Tan YE; Teo JQ; Rahman NBA; Ng OT; Kalisvar M; Tan AL; Koh TH; Ong RTH
Int J Antimicrob Agents; 2019 Dec; 54(6):709-715. PubMed ID: 31600556
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses.
Lockhart SR; Etienne KA; Vallabhaneni S; Farooqi J; Chowdhary A; Govender NP; Colombo AL; Calvo B; Cuomo CA; Desjardins CA; Berkow EL; Castanheira M; Magobo RE; Jabeen K; Asghar RJ; Meis JF; Jackson B; Chiller T; Litvintseva AP
Clin Infect Dis; 2017 Jan; 64(2):134-140. PubMed ID: 27988485
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization and antifungal susceptibility testing of Candida nivariensis from blood samples - an Iranian multicentre study and a review of the literature.
Arastehfar A; Daneshnia F; Salehi MR; Zarrinfar H; Khodavaisy S; Haas PJ; Roudbary M; Najafzadeh MJ; Zomorodian K; Charsizadeh A; Brouwer C; Pan W; Hagen F; Boekhout T
J Med Microbiol; 2019 May; 68(5):770-777. PubMed ID: 30924763
[TBL] [Abstract][Full Text] [Related]
15. Candida auris candidaemia in Indian ICUs: analysis of risk factors.
Rudramurthy SM; Chakrabarti A; Paul RA; Sood P; Kaur H; Capoor MR; Kindo AJ; Marak RSK; Arora A; Sardana R; Das S; Chhina D; Patel A; Xess I; Tarai B; Singh P; Ghosh A
J Antimicrob Chemother; 2017 Jun; 72(6):1794-1801. PubMed ID: 28333181
[TBL] [Abstract][Full Text] [Related]
16. First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia.
Calvo B; Melo AS; Perozo-Mena A; Hernandez M; Francisco EC; Hagen F; Meis JF; Colombo AL
J Infect; 2016 Oct; 73(4):369-74. PubMed ID: 27452195
[TBL] [Abstract][Full Text] [Related]
17. Categorizing Susceptibility of Clinical Isolates of
Nunnally NS; Damm T; Lockhart SR; Berkow EL
J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33408074
[TBL] [Abstract][Full Text] [Related]
18. APX001A
Arendrup MC; Chowdhary A; Astvad KMT; Jørgensen KM
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104264
[TBL] [Abstract][Full Text] [Related]
19. Multidrug-Resistant
Bajpai V; Govindaswamy A; Sagar S; Kumar S; Garg P; Xess I; Malhotra R; Mathur P
Microb Drug Resist; 2020 Feb; 26(2):145-149. PubMed ID: 31539300
[No Abstract] [Full Text] [Related]
20.
O'Brien B; Chaturvedi S; Chaturvedi V
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
